We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$752M
AUM Growth
+$253M
Cap. Flow
+$268M
Cap. Flow %
35.64%
Top 10 Hldgs %
9.6%
Holding
1,082
New
405
Increased
619
Reduced
41
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 15.2%
2 Healthcare 13.08%
3 Industrials 11.83%
4 Financials 9.36%
5 Consumer Discretionary 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQNT
676
DELISTED
Inteliquent, Inc.
IQNT
$314K 0.04%
17,088
+635
+4% +$11.4K
TOWR
677
DELISTED
Tower International, Inc.
TOWR
$313K 0.04%
11,998
+441
+4% +$12.1K
AGO icon
678
Assured Guaranty
AGO
$3.34B
$310K 0.04%
12,942
+476
+4% +$13.3K
PRIM icon
679
Primoris Services
PRIM
$4.45B
$309K 0.04%
15,584
+576
+4% +$11K
MOD icon
680
Modine Manufacturing
MOD
$10.4B
$305K 0.04%
28,464
+1,733
+6% +$20.7K
CHK
681
DELISTED
Chesapeake Energy Corporation
CHK
$305K 0.04%
137
+24
+21% +$67.7K
BYD icon
682
Boyd Gaming
BYD
$6.06B
$302K 0.04%
20,229
+747
+4% +$10.6K
AIMC
683
DELISTED
Altra Industrial Motion Corp
AIMC
$302K 0.04%
11,107
+411
+4% +$11.5K
TEN
684
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$300K 0.04%
5,226
+191
+4% +$11.3K
NJR icon
685
New Jersey Resources
NJR
$5.58B
$295K 0.04%
10,691
+593
+6% +$17.7K
AAIC
686
DELISTED
Arlington Asset Investment Corp.
AAIC
$295K 0.04%
15,097
+994
+7% +$21.7K
INFI
687
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$295K 0.04%
26,964
+1,002
+4% +$12.9K
IOSP icon
688
Innospec
IOSP
$2.28B
$294K 0.04%
6,520
+438
+7% +$19.6K
TKR icon
689
Timken Company
TKR
$9.03B
$291K 0.04%
7,948
+532
+7% +$21.2K
ETD icon
690
Ethan Allen Interiors
ETD
$603M
$289K 0.04%
10,969
+747
+7% +$19.3K
SMP icon
691
Standard Motor Products
SMP
$911M
$289K 0.04%
8,239
+304
+4% +$11.6K
XCO
692
DELISTED
Exco Resources
XCO
$289K 0.04%
16,337
+944
+6% +$24.7K
EGL
693
DELISTED
Engility Holdings, Inc.
EGL
$289K 0.04%
11,471
+424
+4% +$12K
ALB icon
694
Albemarle
ALB
$15.5B
$286K 0.04%
5,177
+336
+7% +$20.1K
MTZ icon
695
MasTec
MTZ
$21.9B
$284K 0.04%
14,293
+526
+4% +$9.83K
PIPR icon
696
Piper Sandler
PIPR
$5.29B
$282K 0.04%
25,860
+936
+4% +$11.7K
BBG
697
DELISTED
Bill Barrett Corp
BBG
$282K 0.04%
32,833
+1,221
+4% +$11.4K
PEI
698
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$281K 0.04%
878
+32
+4% +$10.8K
OFG icon
699
OFG Bancorp
OFG
$2.21B
$280K 0.04%
26,265
+972
+4% +$13.9K
WTI icon
700
W&T Offshore
WTI
$518M
$280K 0.04%
51,150
+1,887
+4% +$10.8K

Similar funds

Vident Investment Advisory's Q2 2015 Portfolio in Review

As of Q2 2015, Vident Investment Advisory held 1,082 positions worth $752M, up 51% from $498M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Vident Investment Advisory deployed $268M of net new capital in Q2 2015, opening 405 new positions and adding to 619 existing holdings. Its largest new stake was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, an estimated $2.86M trimmed.

  • Vident Investment Advisory's largest Q2 2015 buy was iPath ETNs Linked to the MSCI India Total Return Index: 244,802 shares worth $17.2M.
  • Vident Investment Advisory added most to Apple in Q2 2015, an estimated $7.52M increase.
  • Vident Investment Advisory's biggest Q2 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $2.86M.
  • Vident Investment Advisory fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $1.98M.
  • Vident Investment Advisory's ten largest holdings make up 9.6% of its $752M portfolio in Q2 2015.
  • Vident Investment Advisory opened 405 new positions and closed 17 in Q2 2015.
  • Vident Investment Advisory's portfolio value rose 51% quarter-over-quarter to $752M.

Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.